Stem cells tested as potential therapy for COVID-19 in trial at University of Maryland medical school

Researchers at the University of Maryland School of Medicine are participating in a trial of an experimental stem cell therapy for some of the sickest COVID-19 patients who are on ventilators. The study is one of many going on in Maryland and elsewhere that are testing existing drug therapies, as well as new ones to treat the disease caused by the coronavirus. This drug was developed by Mesoblast Limited, an Australian company that develops cell therapies. It is designed for those with moderate to severe cases of severe acute respiratory distress syndrome, called ARDS. The trial will assess whether it shortens recovery time and reduces death from COVID-19. (Balt Sun)

Read Full Article